Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.

Original publication

DOI

10.1016/j.ccr.2008.11.012

Type

Journal article

Journal

Cancer Cell

Publication Date

06/01/2009

Volume

15

Pages

35 - 44

Keywords

Animals, Basement Membrane, Bone Marrow Cells, Breast Neoplasms, Cell Differentiation, Cell Line, Tumor, Cell Movement, Cell Separation, Collagen Type IV, Disease Progression, Enzyme Activation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Hypoxia, Lung Neoplasms, Matrix Metalloproteinase 2, Mice, Mice, Nude, Myeloid Cells, Neoplasm Metastasis, Protein-Lysine 6-Oxidase, Xenograft Model Antitumor Assays